Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Number of holders
-
329
-
Total 13F shares, excl. options
-
73,245,840
-
Shares change
-
+1,777,618
-
Total reported value, excl. options
-
$5,516,516,594
-
Value change
-
-$252,303,319
-
Put/Call ratio
-
110%
-
Number of buys
-
190
-
Number of sells
-
-191
-
Price
-
$75.32
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q3 2019
474 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2019.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 329 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73,245,840 shares
of 105,632,895 outstanding shares and own 69% of the company stock.
Largest 10 shareholders include FMR LLC (8,062,097 shares), VANGUARD GROUP INC (6,365,230 shares), BlackRock Inc. (4,505,741 shares), SANDS CAPITAL MANAGEMENT, LLC (3,952,090 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,788,069 shares), JANUS HENDERSON GROUP PLC (2,305,340 shares), FIL Ltd (2,254,932 shares), STATE STREET CORP (2,193,055 shares), Invesco Ltd. (1,819,026 shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1,724,956 shares).
This table shows the top 329 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.